SCHEMBL2533170

SCHEMBL2533170

CC(C)(C)CC(C)(C)OC(=O)/C=C\C(=O)OC(C)(C)CC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 4/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533174 1.00 HCAR2 (0.36) HCAR2KEAP1NFE2L2ATM
SCHEMBL28621852 0.98 HCAR2 (0.35) HCAR2KEAP1NFE2L2ATM
SCHEMBL1578519 0.92 HCAR2 (0.45) HCAR2KEAP1NFE2L2
SCHEMBL28653107 0.92 HCAR2 (0.45) HCAR2KEAP1NFE2L2
SCHEMBL23919465 0.92 HCAR2 (0.52) HCAR2KEAP1NFE2L2
SCHEMBL21160036 0.87
SCHEMBL13783626 0.84
SCHEMBL19732095 0.84 GABRP (0.32)
SCHEMBL20964489 0.82 HCAR2 (0.46) HCAR2KEAP1NFE2L2
SCHEMBL1108027 0.82 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983462-B1 AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS BASF SE (DE) 2025-01-08 EP disclosed
EP-4133046-B1 POLYMER COMPOSITION, WHICH IS SUITABLE AS ANTI-GREYING AGENT IN DETERGENT FORMULATIONS BASF SE (DE) 2024-05-22 EP disclosed
US-20230174900-A1 POLYMER COMPOSITION, WHICH IS SUITABLE AS ANTI-GREYING AGENT IN DETERGENT FORMULATIONS BASF SE (DE) 2023-06-08 US disclosed
EP-4133046-A1 POLYMER COMPOSITION, WHICH IS SUITABLE AS ANTI-GREYING AGENT IN DETERGENT FORMULATIONS BASF SE (DE) 2023-02-15 EP disclosed
CN-115362248-A Polymer composition suitable as anti-graying agent in detergent formulations 巴斯夫欧洲公司 2022-11-18 CN disclosed
US-20220306791-A1 AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS BASF SE (DE) 2022-09-29 US disclosed
US-11427728-B2 Method for producing aqueous dispersions BASF SE (DE) 2022-08-30 US disclosed
EP-3983462-A1 AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS BASF SE (DE) 2022-04-20 EP disclosed
US-11292861-B2 Aqueous polymer dispersion BASF SE (DE) 2022-04-05 US disclosed
CN-109563192-B Aqueous polymer dispersions 巴斯夫欧洲公司 2021-09-28 CN disclosed
WO-2018019977-A1 AQUEOUS POLYMER DISPERSION BASF SE (DE) 2018-02-01 WO disclosed
EP-3263209-A1 MEMBRANES COMPRISING POLYMERIC PARTICLE LAYERS BASF SE (DE) 2018-01-03 EP disclosed
US-9382442-B2 Aqueous binder compositions BASF SE (DE) 2016-07-05 US disclosed
EP-2855579-B1 AQUEOUS BINDER COMPOSITIONS BASF SE (DE) 2016-03-16 EP disclosed
US-20150099843-A1 AQUEOUS BINDER COMPOSITIONS BASF SE (DE) 2015-04-09 US disclosed
EP-2855579-A1 AQUEOUS BINDER COMPOSITIONS BASF SE (DE) 2015-04-08 EP disclosed
WO-2013174894-A1 AQUEOUS BINDER COMPOSITIONS BASF SE (DE) 2013-11-28 WO disclosed
US-8329800-B2 Binder compositions comprising boric acid or boric acid salt BASF SE (DE) 2012-12-11 US disclosed
US-20110312240-A1 AQUEOUS BINDER COMPOSITIONS BASF SE (DE) 2011-12-22 US disclosed
US-20110257302-A1 BINDER COMPOSITIONS COMPRISING BORIC ACID OR BORIC ACID SALT BASF SE (DE) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306791-A1 AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS LPO, SORD, GYS1 HCAR2 4603/4885KEAP1 1416/4885NFE2L2 3146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.